Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3Paraproteinemias 2Immunoglobulin Light-chain Amyloidosis 2Recurrence 1Postoperative Complications 1Papillomavirus Infections 1Myelodysplastic Syndromes 1Colorectal Neoplasms 1Advanced Hormone Receptor-Positive Breast Carcinoma 1

Interventions

Specimen Handling 6Human Papillomavirus DNA Tests 4Colposcopy 4Papillomavirus Vaccines 2Human Papillomavirus Recombinant Vaccine nonavalent 2Cisplatin 2Carboplatin 2toripalimab 1epigallocatechin gallate 1Transurethral Resection of Prostate 1Standing Orders 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Platinum 1Methods 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Educational Status 1Early Intervention, Educational 1Drug Therapy 1Docetaxel 1Clinical Protocols 1Chemoradiotherapy 1Bevacizumab 1Benzethonium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × Clinical Protocols × 90 days × Clear all
NCT04206813 2026-04-29

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Boston Medical Center

Phase 4 Active not recruiting
352 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡